Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Cognitive Dysfunction × Metformin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 21 Insulin Resistance 5 Obesity 4 Neoplasms 3 Prostatic Neoplasms 2 Motor Activity 2 Menstruation Disturbances 2 Medulloblastoma 2 Infertility 2 Diabetes Mellitus 2 Breast Neoplasms 2 Weight Loss 1 Vitamin D Deficiency 1 Triple Negative Breast Neoplasms 1 Toxemia 1 Thyroid Neoplasms 1 Premature Birth 1 Pregnancy Complications 1 Prediabetic State 1 Pre-Eclampsia 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Non-DM Stage II High-risk Colorectal Cancer 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Metabolic Syndrome 1 Liver Neoplasms 1 Infertility, Female 1 Hyperinsulinism 1 Hyperandrogenism 1

Interventions

mazdutide 1 Tablets 1 Sugars 1 Standard of Care 1 Sodium Chloride 1 Radiotherapy, Intensity-Modulated 1 Metformin 1 Memantine 1 Hormones 1 G(M1) Ganglioside 1 Exercise 1 Donepezil 1 Counseling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05230758 2026-01-22

Met Med Can

The Hospital for Sick Children

Phase 3 Recruiting

Medulloblastoma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡